Cargando…

Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?

PURPOSE: Methotrexate (MTX) is the first choice conventional disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis. It is not universally effective, however; although to date it is not possible to predict with any accuracy which patients will respond to treatment. The aim of this ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hider, S L, Silman, A J, Thomson, W, Lunt, M, Bunn, D, Symmons, D P M
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2009
Materias:	Clinical and Epidemiological Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596302/ https://www.ncbi.nlm.nih.gov/pubmed/18292102 http://dx.doi.org/10.1136/ard.2008.088237

Ejemplares similares

Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis
por: Farragher, Tracey M, et al.
Publicado: (2009)

The relationship between post-onset pregnancy and functional outcome in women with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register
por: Camacho, E M, et al.
Publicado: (2010)

Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register
por: Scirè, Carlo A, et al.
Publicado: (2014)

Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis
por: Franklin, Jarrod, et al.
Publicado: (2010)

In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register
por: Verstappen, Suzanne M M, et al.
Publicado: (2011)

The performance of anti–cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: Results from the Norfolk Arthritis Register
por: Bukhari, M, et al.
Publicado: (2007)

Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients
por: Goodson, N J, et al.
Publicado: (2008)

N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR)
por: Mirjafari, Hoda, et al.
Publicado: (2014)

Association of Morbid Obesity With Disability in Early Inflammatory Polyarthritis: Results From the Norfolk Arthritis Register
por: Humphreys, J H, et al.
Publicado: (2013)

Demographic and disease-related predictors of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population
por: Verstappen, Suzanne M M, et al.
Publicado: (2013)

Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register—the EPIC-2-NOAR Study)
por: Lahiri, Manjari, et al.
Publicado: (2014)

Benefit of early treatment in inflammatory polyarthritis patients with anti–cyclic citrullinated peptide antibodies versus those without antibodies
por: Farragher, Tracey M, et al.
Publicado: (2010)

The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register
por: Plant, Darren, et al.
Publicado: (2011)

Learned helplessness predicts functional disability, pain and fatigue in patients with recent-onset inflammatory polyarthritis
por: Camacho, Elizabeth M., et al.
Publicado: (2013)

The PTPN22*C1858T functional polymorphism is associated with susceptibility to inflammatory polyarthritis but neither this nor other variants spanning the gene is associated with disease outcome
por: Naseem, H, et al.
Publicado: (2008)

The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis
por: Naz, Sophia M, et al.
Publicado: (2008)

Reduction of Long-Term Disability in Inflammatory Polyarthritis by Early and Persistent Suppression of Joint Inflammation: Results From the Norfolk Arthritis Register
por: Scirè, Carlo A, et al.
Publicado: (2011)

Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study
por: Mirjafari, Hoda, et al.
Publicado: (2011)

Influence of Inflammatory Polyarthritis on Quantitative Heel Ultrasound Measurements
por: Pye, Stephen R, et al.
Publicado: (2012)

Association of the HLA–DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis
por: Farragher, Tracey M, et al.
Publicado: (2008)

Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register
por: Cook, Michael J., et al.
Publicado: (2016)

Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients
por: Farragher, Tracey M, et al.
Publicado: (2010)

Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis Register
por: Camacho, E M, et al.
Publicado: (2011)

Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study
por: Bluett, James, et al.
Publicado: (2018)

Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis
por: Burr, Marian L, et al.
Publicado: (2012)

Association of Functional Outcome With Both Personal- and Area-Level Socioeconomic Inequalities in Patients With Inflammatory Polyarthritis
por: Harrison, Mark J, et al.
Publicado: (2009)

Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register
por: Gwinnutt, James M, et al.
Publicado: (2018)

Association between socioeconomic status, learned helplessness, and disease outcome in patients with inflammatory polyarthritis
por: Camacho, E M, et al.
Publicado: (2012)

Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate
por: Humphreys, Jenny H, et al.
Publicado: (2017)

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
por: Dixon, W G, et al.
Publicado: (2010)

Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register
por: Humphreys, Jennifer H, et al.
Publicado: (2016)

Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis
por: Viatte, Sebastien, et al.
Publicado: (2016)

Influence of arthritis and non-arthritis related factors on areal bone mineral density (BMD(a)) in women with longstanding inflammatory polyarthritis: a primary care based inception cohort
por: Pye, Stephen R, et al.
Publicado: (2010)

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
por: Dixon, W G, et al.
Publicado: (2009)

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
por: Soliman, Moetaza M, et al.
Publicado: (2011)

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti‑TNF therapy: results from the British Society for Rheumatology Biologics Register
por: Davies, Rebecca, et al.
Publicado: (2011)

Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
por: Smolen, Josef S, et al.
Publicado: (2018)

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
por: Potter, C, et al.
Publicado: (2009)

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Mercer, Louise K, et al.
Publicado: (2015)

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
por: Baranauskaite, Asta, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_12bnn1g0bheionmk8ik19j041f